Meeting Objectives: Pharma/Biotech Project Portfolio Management Summit

June 2017



Tryp Barcelona Apolo Hotel

Av. del Paral.lel 57-59, 08004

About Summit

Due to the nature of Pharma/Biotech R&D, it is a costly, time-consuming affair, notwithstanding the ever-growing competition and fluctuating environments. Developing drug portfolios demands PPM to be highly innovative, structured and well organised. Vonlanthen Group of Companies shall be hosting an event to overcome these challenges, through an expert panel of speakers and delegates to discuss, innovate and resolve critical issues for fast track solutions to complex PPM problems.

Who Should Attend

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders and Managers specialising in:

  • Portfolio Management
  • Portfolio Analysis
  • Portfolio Analytics
  • Project Management
  • Program Management
  • Capacity Management
  • Strategy Development
  • Clinical Development
  • Investment Support
  • Corporate Strategy
  • Business Development
  • Portfolio Development
  • Portfolio Planning
  • Portfolio Sourcing
  • Project Planning
  • Resource Management
  • Strategic Planning
  • R&D Operations
  • Alliance Management
  • Decision Support
  • Corporate Development
  • Marketing

From Industries:

  • Pharmaceutical
  • Medical devices
  • Biotechnology
Key Practical Learning Points of the Summit

  • Engaging R&D teams to drive product cycles
  • Holistic and transparent approaches through the pipeline
  • Determining the most viable projects
  • Restructuring and reforecasting project portfolios
  • Mastering the role of PPM in internal and external collaborations
  • Maximising PPM tool efficiency and organic interaction
  • Extracting quality data from mass information feeds
  • An in-depth look into mitigating uncertainty
Christoph Kalis

Associate Director PMO


Dr. Simon Preston

Global Regulatory Affairs, Patient Safety and Quality Assurance


Dr. Dorothee Breuer-Giersiepen

Director Clinical Project Management, Real-World Evidence Solutions


Sigrún Stefánsdóttir

Director Strategic Launch Management & PMO

Actavis - a Teva company

Alexis Poulet

Global Head of R&D Finance & Controlling

Ferring Pharmaceuticals

Kamil Mroz

Managing Director


David Carrasco

Strategic Operations Director, Real-World Evidence Solutions


Dr. Kenny Blades

Director, Global Program Management DOCS / ICON


Anna Aillerie

Director - Commercial Biosimilars EMEA


Frank Berger

Head, Study Budget CoE, Global Clinical Operations

Boehringer Ingelheim

Dr. Donatienne Phillips

Business Director - Early Development


Denise Moody

Senior Director Project Management FSP


Sponsors and Partners

Media partner

Media partner

Media partner

Media partner

Media partner